Просмотр по автору "Kaidarova, D."

Отображаемые элементы 1-1 из 1

Assessment of safety and tolerability of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: Results of an open-label, randomized, multicenter, phase IIIB ESCAPE trial

Kaidarova, D.; Zhavrid, E.; Shatkovskaya, O.; Prokharau, A.; Akhmed, N.; Sembayev, D.; Rutzhanova, Z.; Ivankov, A. (2024)

Aim: To assess the safety and tolerability of subcutaneous (SC) trastuzumab (Herceptin) administered either with a single-use injection device (SID) or manually from a vial using a hand-held syringe. Methods: The ESCAPE ...